XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Common stock, par value $.01 per share
Additional paid-in capital
Retained earnings
Retained earnings
Cumulative adjustments for changes in accounting principles
Treasury stock
Accumulated other comprehensive income/ (loss)
Total equity attributable to Raymond James Financial, Inc.
Noncontrolling interests
Balance beginning of period at Sep. 30, 2020   $ 2 $ 2,007 $ 6,484 $ (35) $ (1,390) $ 11   $ 62
Changes in Shareholders' Equity:                  
Accounting Standards Update [Extensible List] Accounting Standards Update 2016-13 [Member]                
Balance end of period at Dec. 31, 2020   2 1,996 6,702 0 (1,354) 17   75
Balance beginning of period at Sep. 30, 2020   2 2,007 6,484 (35) (1,390) 11   62
Changes in Shareholders' Equity:                  
Share issuances   0              
Employee stock purchases     15            
Reissuances (distributions) due to vesting of restricted stock units and exercise of stock options, net of forfeitures     (66)     65      
Share-based compensation amortization     72            
Net income attributable to Raymond James Financial, Inc. $ 667     667          
Cash dividends declared (see Note 22)       (112)          
Purchases/surrenders           (79)      
Other comprehensive income/(loss), net of tax (49)           (49)    
Net income/(loss) attributable to noncontrolling interests                 12
Deconsolidations and sales                 (29)
Balance end of period at Mar. 31, 2021 7,637 2 2,028 7,004   (1,404) (38) $ 7,592 45
Balance beginning of period at Dec. 31, 2020   2 1,996 6,702 0 (1,354) 17   75
Changes in Shareholders' Equity:                  
Share issuances   0              
Employee stock purchases     9            
Reissuances (distributions) due to vesting of restricted stock units and exercise of stock options, net of forfeitures     (7)     11      
Share-based compensation amortization     30            
Net income attributable to Raymond James Financial, Inc. 355     355          
Cash dividends declared (see Note 22)       (53)          
Purchases/surrenders           (61)      
Other comprehensive income/(loss), net of tax (55)           (55)    
Net income/(loss) attributable to noncontrolling interests                 (1)
Deconsolidations and sales                 (29)
Balance end of period at Mar. 31, 2021 7,637 2 2,028 7,004   (1,404) (38) 7,592 45
Balance beginning of period at Sep. 30, 2021 8,303 2 2,088 7,633 0 (1,437) (41)   58
Changes in Shareholders' Equity:                  
Share issuances   0              
Employee stock purchases     22            
Reissuances (distributions) due to vesting of restricted stock units and exercise of stock options, net of forfeitures     (122)     87      
Share-based compensation amortization     105            
Net income attributable to Raymond James Financial, Inc. 769     769          
Cash dividends declared (see Note 22)       (146)          
Purchases/surrenders           (10)      
Other comprehensive income/(loss), net of tax (348)           (348)    
Net income/(loss) attributable to noncontrolling interests                 0
Deconsolidations and sales                 (51)
Balance end of period at Mar. 31, 2022 8,609 2 2,093 8,256   (1,360) (389) 8,602 7
Balance beginning of period at Dec. 31, 2021   2 2,055 8,003 $ 0 (1,373) (87)   52
Changes in Shareholders' Equity:                  
Share issuances   0              
Employee stock purchases     14            
Reissuances (distributions) due to vesting of restricted stock units and exercise of stock options, net of forfeitures     (17)     13      
Share-based compensation amortization     41            
Net income attributable to Raymond James Financial, Inc. 323     323          
Cash dividends declared (see Note 22)       (70)          
Purchases/surrenders           0      
Other comprehensive income/(loss), net of tax (302)           (302)    
Net income/(loss) attributable to noncontrolling interests                 (2)
Deconsolidations and sales                 (43)
Balance end of period at Mar. 31, 2022 $ 8,609 $ 2 $ 2,093 $ 8,256   $ (1,360) $ (389) $ 8,602 $ 7